Phio Pharmaceuticals (PHIO) EBITDA Margin (QoQ) (2012 - 2018)
Phio Pharmaceuticals (PHIO) EBITDA Margin (QoQ) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Phio Pharmaceuticals | 13.94 Mn | 13.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 65,659.00 |
| Jun 30, 2018 | 646,064.00 |
| Mar 31, 2018 | 353,855.00 |
| Jun 30, 2016 | -216,111.00 |
| Mar 31, 2015 | 780,672.00 |
| Dec 31, 2014 | -266,518.00 |
| Sep 30, 2014 | 303,542.00 |
| Jun 30, 2014 | -894,511.00 |
| Mar 31, 2014 | 78,621.00 |
| Dec 31, 2013 | -643,167.00 |
| Sep 30, 2013 | -137,775.00 |
| Jun 30, 2013 | 2.63 Mn |
| Mar 31, 2013 | -2.29 Mn |
| Dec 31, 2012 | -130,456.00 |